NIAID Banner Logo Image

Opportunistic Infections Citation List:

May 28- June 10, 2010

OPPORTUNISTIC PROTOZOA COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])

1. The effect of prolactin (PRL) on the growth of Toxoplasma gondii tachyzoites in vitro. Dzitko, K., J. Gatkowska, P. Plocinski, B. Dziadek, and H. Dlugonska. Parasitol Res. 107(1): p. 199-204; PMID[20397028].

[Pubmed]. OI_0528-061010.

ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

2. Uptake of T-2307, a novel arylamidine, in Candida albicans. Nishikawa, H., E. Yamada, T. Shibata, S. Uchihashi, H. Fan, H. Hayakawa, N. Nomura, and J. Mitsuyama. J Antimicrob Chemother. [Epub ahead of print]; PMID[20513704].

[Pubmed]. OI_0528-061010.

3. Antifungal activity of essential oils and their constituents against Candida Spp. and their effects on activity of amphotericin B. Nozaki, A., E. Takahashi, K. Okamoto, H. Ito, and T. Hatano. Yakugaku Zasshi. 130(6): p. 895-902; PMID[20519869].

[Pubmed]. OI_0528-061010.

4. Potential synergistic activity of antimycotic substances in combination with human platelets against Aspergillus fumigatus. Perkhofer, S., K. Trappl, W. Nussbaumer, M.P. Dierich, and C. Lass-Florl. J Antimicrob Chemother. 65(6): p. 1309-11; PMID[20378674].

[Pubmed]. OI_0528-061010.

5. Synthesis and in vitro study of methylene-bis-tetrahydro[1,3]thiazolo[4,5-c]isoxazoles as potential nematicidal agents. Srinivas, A., A. Nagaraj, and C.S. Reddy. Eur J Med Chem. 45(6): p. 2353-8; PMID[20199825].

[Pubmed]. OI_0528-061010.

6. Isavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole. Mycopathologia. Thompson, G.R., 3rd and N.P. Wiederhold. [Epub ahead of print]; PMID[20524153].

[Pubmed]. OI_0528-061010.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

7. In vitro and in vivo Activities of a New Lead Compound I2906 against Mycobacterium tuberculosis. Lu, J., J. Yue, J. Wu, R. Luo, Z. Hu, J. Li, Y. Bai, Z. Tang, Q. Xian, X. Zhang, and H. Wang. Pharmacology. 85(6): p. 365-371; PMID[20530976].

[Pubmed]. OI_0528-061010.

8. Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth. Mascarello, A., L.D. Chiaradia, J. Vernal, A. Villarino, R.V. Guido, P. Perizzolo, V. Poirier, D. Wong, P.G. Martins, R.J. Nunes, R.A. Yunes, A.D. Andricopulo, Y. Av-Gay, and H. Terenzi. Bioorg Med Chem. 18(11): p. 3783-9; PMID[20462762].

[Pubmed]. OI_0528-061010.

9. TMC207: the first compound of a new class of potent anti-tuberculosis drugs. Matteelli, A., A.C. Carvalho, K.E. Dooley, and A. Kritski. Future Microbiol. 5(6): p. 849-58; PMID[20521931].

[Pubmed]. OI_0528-061010.

10. Mycobacterium tuberculosis and sulfamethoxazole susceptibility. Ong, W., A. Sievers, and D.E. Leslie. Antimicrob Agents Chemother. 54(6): p. 2748; author reply 2748-9; PMID[20479209].

[Pubmed]. OI_0528-061010.

11. In Vitro Antituberculosis Activities of ACH-702, a Novel Isothiazoloquinolone, against Quinolone-Susceptible and Quinolone-Resistant Isolates. Pucci, M.J., M. Ackerman, J.A. Thanassi, C.M. Shoen, and M.H. Cynamon. Antimicrob Agents Chemother. [Epub ahead of print]; PMID[20516287].

[Pubmed]. OI_0528-061010.

12. Synthesis and biological evaluation of pyrimidine analogs of antimycobacterial purines. Read, M.L., M. Braendvang, P.O. Miranda, and L.L. Gundersen. Bioorg Med Chem. 18(11): p. 3885-97; PMID[20488716].

[Pubmed]. OI_0528-061010.

13. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. Sharma, S., M. Kumar, A. Nargotra, S. Koul, and I.A. Khan. J Antimicrob Chemother. [Epub ahead of print]; PMID[20525733].

[Pubmed]. OI_0528-061010.

Citations from the ISI Web of Knowledge Listings for O.I.

14. In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species. Andes, D., D.J. Diekema, M.A. Pfaller, J. Bohrmuller, K. Marchillo, and A. Lepak. Antimicrobial Agents and Chemotherapy. 54(6): p. 2497-2506; ISI[000277756000028].

[WOS]. OI_0528-061010.

15. Pyrrole-Based Hydrazones Synthesized and Evaluated In Vitro as Potential Tuberculostatics. Bijev, A. and M. Georgieva. Letters in Drug Design & Discovery. 7(6): p. 430-437; ISI[000277887000007].

[WOS]. OI_0528-061010.

16. New Mycobacterium Tuberculosis DNA Gyrase Inhibitors: Naphthyridone Series Against Tb. Guardia, A., D. Barros, and M.J. Remuinan. Drugs of the Future, 2009. 34: p. 185-185; ISI[000274983700156].

[WOS]. OI_0528-061010.

17. Selective one-pot multicomponent synthesis and anti-tubercular evaluation of 5-(aryl/cyclohexylsulfanyl)-2-alkoxy-4,6-diarylnicotinonitriles. Manikannan, R., S. Muthusubramanian, P. Yogeeswari, and D. Sriram. Bioorganic & Medicinal Chemistry Letters. 20(11): p. 3352-3355; ISI[000277788900034].

[WOS]. OI_0528-061010.

18. In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi. Nyilasi, I., S. Kocsube, K. Krizsan, L. Galgoczy, M. Pesti, T. Papp, and C. Vagvolgyi. Fems Microbiology Letters. 307(2): p. 175-184; ISI[000277794500010].

[WOS]. OI_0528-061010.

19. Spectral characterization and antimicrobial activity of Cu(II) and Fe(III) complexes of 2-(5-Cl/NO2-1H-benzimidazol-2-yl)-4-Br/NO2-phenols. Tavman, A., I. Boz, A.S. Birteksoz, and A. Cinarli. Journal of Coordination Chemistry. 63(8): p. 1398-1410; ISI[000277737700012].

[WOS]. OI_0528-061010.

20. Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal Agents. van de Sande, W.W.J., A.H. Fahal, I. Bakker-Woudenberg, and A. van Belkum. Antimicrobial Agents and Chemotherapy. 54(6): p. 2738-2740; ISI[000277756000069].

[WOS]. OI_0528-061010.

21. Synthesis, characterization and biocidal activities of heterobimetallic complexes having tin(IV) as a padlock. Husain, A., S.A.A. Nami, and K.S. Siddiqi. Journal of Molecular Structure. 970(1-3): p. 117-127; ISI[000277761500017].

[WOS]. OI_0528-061010.

22. Antimicrobial and DNA Cleavage Studies of New N2O2 Diazadioxa Macrocyclic Schiff Base Co(II), Ni(II) and Cu(II) Complexes Containing Triazole Head Unit: Synthesis and Spectroscopic Approach. Patil, S.A., U.V. Kamble, and P.S. Badami. Journal of Macromolecular Science Part A-Pure and Applied Chemistry. 47(6): p. 510-520; ISI[000277588600004].

[WOS]. OI_0528-061010.

23. Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma. Lourido, S., J. Shuman, C. Zhang, K.M. Shokat, R. Hui, and L.D. Sibley. Nature. 465(7296): p. 359-U118; ISI[000277829200043].

[WOS]. OI_0528-061010.

24. Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthase. Talukdar, A., E. Morgunova, J.X. Duan, W. Meining, N. Foloppe, L. Nilsson, A. Bacher, B. Illarionov, M. Fischer, R. Ladenstein, and M. Cushman. Bioorganic & Medicinal Chemistry. 18(10): p. 3518-3534; ISI[000277545900016].

[WOS]. OI_0528-061010.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2021